Pandemic-driven healthcare disruptions and their disproportionate impact on patients with diabetes: evidence from Texas

The COVID-19 pandemic significantly impacted DKA outcomes through the direct effects of SARS-CoV-2 infection and through various healthcare system disruptions-such as reduced access to routine diabetes care, delays in seeking treatment, and hospital resource constraints. Policies supporting uninterrupted diabetes management, such as telemedicine and medication access programs may reduce adverse outcomes in future health crises.